MOLN Molecular
- 3.870
- +0.089+2.35%
Molecular News
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 20-F: Registration statement / Annual report / Transition report
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | SC 13D: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(23.9%),BVF Inc.(23.9%), etc.
Molecular | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(17.9%),BVF Inc.(17.9%), etc.
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer (related to financial reporting)
Molecular | 6-K: Report of foreign private issuer (related to financial reporting)
Molecular | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Molecular | 6-K: Report of foreign private issuer (related to financial reporting)
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular: FY2022 Annual Report
20-F | MOLECULAR PARTNERS AG (0001745114) (Filer)
Molecular | 6-K: Report of foreign private issuer (related to financial reporting)
Molecular | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(12.6%),BVF Inc.(12.6%), etc.
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
